Arialys Therapeutics

Home Team News Careers Contact

News

« Back to News

August 8, 2024

PharmaVoice Biotech Spotlight: A Biotech Dousing ‘Fires’ in the Brain that Plagued a Bestselling Author

Arialys was featured in PharmaVoice's Biotech Spotlight, a series featuring companies creating breakthrough technologies and products.

In this article, Arialys' CEO Peter Flynn shares more about the vision of the company, why it matters, the terrifying and rapid symptoms of anti-NMDA receptor encephalitis (ANRE) and how ART-5803, our lead therapeutic candidate to treat autoimmune psychosis is “elegantly simple.”

Read the article here.

‍

Sign up for news updates

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

Follow us

©2024 Arialys Therapeutics, 11099 North Torrey Pines Rd., Ste 290, La Jolla, CA 92037